
Christiane Truelove
Writer and Editor at Freelance
Contributing Editor at Med Ad News Magazine
Contributing editor, Med Ad News/Outcomes LLC; guest editor, AMA Quarterly; freelance writer
Articles
-
2 months ago |
pharmalive.com | Christiane Truelove
DEI and clinical trials: An ongoing connectionBy Christiane TrueloveIn 2023, the PAN Foundation, a leading charitable foundation and healthcare advocacy organization, launched several initiatives focused on diversity, equity, and inclusion (DEI) for clinical trials.
-
2 months ago |
pharmalive.com | Christiane Truelove
Pharma people on the move: Winter 2025 roundupBy Christiane Truelove | [email protected]EMD Serono lead for North American healthcare business EMD Serono, the healthcare business of Merck KGaA in the United States and Canada, appointed Miguel Fernández Alcalde as president of EMD Serono.
-
2 months ago |
pharmalive.com | Christiane Truelove
No answers for future valueBy Christiane Truelove | [email protected]Less than two weeks after Donald Trump was sworn in as president of the United States, issues of drug pricing continue to take a back seat, drowned out by a Sharpie-emblazoned tsunami of executive orders from the Oval Office on moves such as eliminating all language about DEI on every government website and freezing federal grants and aid.
-
Dec 9, 2024 |
pharmalive.com | Christiane Truelove
Staying the course for DEIThough President-elect Trump’s agenda may threaten the advance of DEI programs in all areas, biopharma companies and their healthcare agencies must keep up their efforts for diversity in the workplace and clinical trials. By Christiane Truelove | [email protected]The results of the November 6 presidential election may be a reckoning for the pharma industry in many ways, but for once the discussion isn’t about drug prices.
-
Oct 24, 2024 |
pharmalive.com | Christiane Truelove
Roche on Thursday inked its second research collaboration deal with Dyno Therapeutics to advance next-generation gene therapies for neurological diseases. Under the terms of the agreement, Roche will make an upfront payment of $50 million and pledge more than $1 billion in preclinical, clinical and commercial milestones, plus royalties on net sales of any product that arises from the partnership.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 18K
- DMs Open
- No

RT @EtherOfTruth: https://t.co/aBfhaBmneN As I'm told that Monday is a great day for new content. Here's a shameless plug for Dispatches fr…

I grew up with guns, but in a state with fairly strict gun control laws. Wondering how many states would allow you to bring home that working pre-1987 machine gun you purchased at Knob Creek. #guns

https://t.co/ENIJ4GjKMZ No humor in this Dispatches. Just tooth and claw as we take on guns in The Cult of Pig Iron and The Taste of Copper. Enjoy!

RT @EtherOfTruth: https://t.co/QTlPmuTbNq <--- Alright, word fam - I don't settle for Dispatches that only get 12 views so....... Maybe do…